睡眠性-话题@MedSci

#睡眠性#

5篇内容 | 250人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1800753, encodeId=a4a51800e53e5, content=<a href='/topic/show?id=3261e3003ad' target=_blank style='color:#2F92EE;'>#睡眠性#</a>, objectTitle=NEJM：Pegcetacoplan对于阵发性睡眠性血红蛋白尿的治疗效果优于Eculizumab, objectType=article, longId=208673, objectId=25e82086e3fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25e82086e3fe, replyNumber=0, likeNumber=43, createdTime=2021-08-20, rootId=0, userName=makuansheng, userId=2ba9118, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25e82086e3fe, moduleTitle=NEJM：Pegcetacoplan对于阵发性睡眠性血红蛋白尿的治疗效果优于Eculizumab, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25e82086e3fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1800752, encodeId=82681800e5224, content=<a href='/topic/show?id=3261e3003ad' target=_blank style='color:#2F92EE;'>#睡眠性#</a>, objectTitle=每周一次皮下注射C5补体抑制剂ULTOMIRIS，治疗阵发性睡眠性血红蛋白尿达到了III期临床终点, objectType=article, longId=196488, objectId=a16319648829, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a16319648829, replyNumber=0, likeNumber=41, createdTime=2020-12-25, rootId=0, userName=makuansheng, userId=2ba9118, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a16319648829, moduleTitle=每周一次皮下注射C5补体抑制剂ULTOMIRIS，治疗阵发性睡眠性血红蛋白尿达到了III期临床终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a16319648829)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1800751, encodeId=e50d1800e5178, content=<a href='/topic/show?id=3261e3003ad' target=_blank style='color:#2F92EE;'>#睡眠性#</a>, objectTitle=欧盟批准C5补体抑制剂ULTOMIRIS用于治疗阵发性睡眠性血红蛋白尿（PNH）成人患者, objectType=article, longId=174812, objectId=e3031e48124f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3031e48124f, replyNumber=0, likeNumber=37, createdTime=2019-10-09, rootId=0, userName=makuansheng, userId=2ba9118, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3031e48124f, moduleTitle=欧盟批准C5补体抑制剂ULTOMIRIS用于治疗阵发性睡眠性血红蛋白尿（PNH）成人患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3031e48124f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1800750, encodeId=4ecb1800e503b, content=<a href='/topic/show?id=3261e3003ad' target=_blank style='color:#2F92EE;'>#睡眠性#</a>, objectTitle=Blood：Ravulizumab和依库丽单抗治疗阵发性睡眠性血红蛋白尿的效果对比, objectType=article, longId=155209, objectId=d4bf1552095c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4bf1552095c, replyNumber=0, likeNumber=33, createdTime=2019-07-17, rootId=0, userName=makuansheng, userId=2ba9118, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4bf1552095c, moduleTitle=Blood：Ravulizumab和依库丽单抗治疗阵发性睡眠性血红蛋白尿的效果对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4bf1552095c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1800749, encodeId=1a961800e4920, content=<a href='/topic/show?id=3261e3003ad' target=_blank style='color:#2F92EE;'>#睡眠性#</a>, objectTitle=Intern Med J:阵发性睡眠性血红蛋白尿患者使用依库珠单抗有何临床获益？, objectType=article, longId=117837, objectId=61fc11e837c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61fc11e837c2, replyNumber=0, likeNumber=35, createdTime=2017-11-28, rootId=0, userName=makuansheng, userId=2ba9118, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61fc11e837c2, moduleTitle=Intern Med J:阵发性睡眠性血红蛋白尿患者使用依库珠单抗有何临床获益？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61fc11e837c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

睡眠性

2020-05-29

makuansheng (审核中...)

前往app查看评论内容

#睡眠性#

NEJM：Pegcetacoplan对于阵发性睡眠性血红蛋白尿的治疗效果优于Eculizumab

2021-08-20

makuansheng (审核中...)

前往app查看评论内容

#睡眠性#

每周一次皮下注射C5补体抑制剂ULTOMIRIS，治疗阵发性睡眠性血红蛋白尿达到了III期临床终点

2020-12-25

makuansheng (审核中...)

前往app查看评论内容

#睡眠性#

欧盟批准C5补体抑制剂ULTOMIRIS用于治疗阵发性睡眠性血红蛋白尿（PNH）成人患者

2019-10-09

makuansheng (审核中...)

前往app查看评论内容

#睡眠性#

Blood：Ravulizumab和依库丽单抗治疗阵发性睡眠性血红蛋白尿的效果对比

2019-07-17

makuansheng (审核中...)

前往app查看评论内容

#睡眠性#

Intern Med J:阵发性睡眠性血红蛋白尿患者使用依库珠单抗有何临床获益？

2017-11-28

科室
- - 订阅+
  - 更多科室
工具
服务